REBEKAH CORLEY: Open Payments
NPI 1023352358 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 16 payments from 11 companies in 2025. Trend: 2023 $1,158 · 2024 $1,254 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $82 |
| GENZYME CORPORATION | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Janssen Biotech, Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Braintree Laboratories, Inc. | 1 | $16 |
Products named: DUPIXENT, SKYRIZI, CREON, OMVOH, LINZESS, TREMFYA, IQIRVO, The Cologuard Plus Collection Kit.
Industry payments across GA — which companies pay providers there.
